View all staff
Professor Andy Davies

Professor Andy Davies

 BSc (Hons) BM (Hons) PhD FRCP
Professor of Haematological Oncology

Connect with Andy

Email: A.Davies@soton.ac.uk

Tel: +44 23 8120 6186

Address: ¾ÅÉ«ÊÓƵ General Hospital, Tremona Road Shirley, SO16 6YD
()
Research Publications
Research Publications

Research

Research groups

Research projects

Active projects

An open, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (PolaRICE) with rituximab, ifosfamide, carboplatin and etoposide (RICE)
Experimental Cancer Medicines Centre (ECMC) 2022 QQR
Researchers:
Professor Andy Davies
Sponsor: Cancer Research UK
CRUK Clinical Academic Training Programme 2024
Experimental Cancer Medicines Centre (ECMC) 2022 QQR
Researchers:
Professor Andy Davies
Cost-effective multi-cancer early detection by measuring patient plasma amino acid cross sections with the Enlighten test
Optimizing MATrix as remission induction treatment for newly diagnosed primary CNS Lymphoma – a randomized phase III trial (OPTIMATE trial)
Sponsor: Cancer Research UK
miONCO-Dx : A novel multi cancer early diagnostic test
(MAIN STUDY) SAFE-D: Surveillance of pAncreatic pathology aFtEr Diabetes diagnosis

Completed projects

Treating Multiple Myeloma and Diffuse Large B Cell Lymphoma by Targeting the NF-κB Pathway with the First-in-Class GADD45β/MKK7 Inhibitor, DTP3
Sponsor: Medical Research Council
TAP Centre within TAP Network
Researchers:
Professor Andy Davies
Sponsor: Cure Leukaemia
UK-Japan AMED
Researchers:
Professor Andy Davies
Molecular Profiling for Lymphoma Study
Sponsor: Blood Cancer UK
Johnson - LLR - 15002 - Precision medicine for aggressive lymphoma
Sponsor: Blood Cancer UK
Understanding and improving the mechanism of action of anti-GD2 monoclonal antibody therapy in neuroblastoma
Sponsor: Childrens Cancer and Leukaemia Group
An Open Label Single Arm Phase II Study of Atezolizumab in patients with non-TCC of the bladder and urothelial tract
Sponsor: Cancer Research UK
(PILOT) SAFE-D: Screening of pAncreatic pathology aFtEr Diabetes diagnosis